Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott E Wolkenberg

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitorsZhijian Zhao, William H Leister, Julie A O'Brien, et al.
Nuclear Medicine and Biology|July 12, 2011
[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkeyEric D Hostetler, Sandra Sanabria-Bohórquez, Hong Fan, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2016
Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitorsZhijian Zhao, Scott T Harrison, Jeffrey W Schubert, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as β-Amyloid PET Ligands and Identification of MK-3328Scott T Harrison, James Mulhearn, Scott E Wolkenberg, et al.
ACS Medicinal Chemistry Letters|April 15, 2021
Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor InteractionDouglas C Beshore, Gregory C Adam, Richard J O Barnard, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Discovery of GlyT1 inhibitors with improved pharmacokinetic propertiesScott E Wolkenberg, Zhijian Zhao, David D Wisnoski, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT)Scott T Harrison, Michael S Poslusney, James J Mulhearn, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)Zhijian Zhao, Scott E Wolkenberg, Philip E J Sanderson, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|January 25, 2011
High concentration electrophysiology-based fragment screen: discovery of novel acid-sensing ion channel 3 (ASIC3) inhibitorsScott E Wolkenberg, Zhijian Zhao, James J Mulhearn, et al.
Bioorganic & Medicinal Chemistry Letters|January 31, 2009
Discovery of N-{[1-(propylsulfonyl)-4-pyridin-2-ylpiperidin-4-yl]methyl}benzamides as novel, selective and potent GlyT1 inhibitorsZhijian Zhao, William H Leister, Julie A O'Brien, et al.
Nuclear Medicine and Biology|July 12, 2011
[18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkeyEric D Hostetler, Sandra Sanabria-Bohórquez, Hong Fan, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2016
Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitorsZhijian Zhao, Scott T Harrison, Jeffrey W Schubert, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Synthesis and Evaluation of 5-Fluoro-2-aryloxazolo[5,4-b]pyridines as β-Amyloid PET Ligands and Identification of MK-3328Scott T Harrison, James Mulhearn, Scott E Wolkenberg, et al.
ACS Medicinal Chemistry Letters|April 15, 2021
Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor InteractionDouglas C Beshore, Gregory C Adam, Richard J O Barnard, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
Discovery of GlyT1 inhibitors with improved pharmacokinetic propertiesScott E Wolkenberg, Zhijian Zhao, David D Wisnoski, et al.
ACS Medicinal Chemistry Letters|March 28, 2015
Synthesis and Evaluation of Heterocyclic Catechol Mimics as Inhibitors of Catechol-O-methyltransferase (COMT)Scott T Harrison, Michael S Poslusney, James J Mulhearn, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
Novel indole-3-sulfonamides as potent HIV non-nucleoside reverse transcriptase inhibitors (NNRTIs)Zhijian Zhao, Scott E Wolkenberg, Philip E J Sanderson, et al.
Bioorganic & Medicinal Chemistry Letters|September 5, 2006
Potent antagonists of the Kv1.5 potassium channel: synthesis and evaluation of analogous N,N-diisopropyl-2-(pyridine-3-yl)acetamidesKausik K Nanda, M Brad Nolt, Matthew J Cato, et al.
Pageof 4